Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Chris A. Brosey, Jerry H. Houl, Panagiotis Katsonis, et al.
Progress in Biophysics and Molecular Biology (2021) Vol. 163, pp. 171-186
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling
Lilian C. Russo, Rebeka Tomasin, Isaac de Araújo Matos, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 3, pp. 101041-101041
Open Access | Times Cited: 95
Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy
Zu Ye, Shi Yin, Susan P. Lees‐Miller, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 55
Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose
Nicholas S. Rhoades, Amanda N. Pinski, Alisha N. Monsibais, et al.
Cell Reports (2021) Vol. 36, Iss. 9, pp. 109637-109637
Open Access | Times Cited: 54
Molecular modelling and structure-activity relationship of a natural derivative of o-hydroxybenzoate as a potent inhibitor of dual NSP3 and NSP12 of SARS-CoV-2: in silico study
Yusuf Oloruntoyin Ayipo, Iqrar Ahmad, Yahaya Sani Najib, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 5, pp. 1959-1977
Open Access | Times Cited: 28
Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis
R. R. Joshi, Harsh Gaikwad, Bhavana Soge, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A molecular toolbox for ADP-ribosyl binding proteins
Sven T. Sowa, Albert Galera‐Prat, Sarah Wazir, et al.
Cell Reports Methods (2021) Vol. 1, Iss. 8, pp. 100121-100121
Open Access | Times Cited: 32
Regulation of Biomolecular Condensates by Poly(ADP-ribose)
Kevin Rhine, Hana M. Odeh, James Shorter, et al.
Chemical Reviews (2023) Vol. 123, Iss. 14, pp. 9065-9093
Closed Access | Times Cited: 14
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors
M. Schuller, Tryfon Zarganes‐Tzitzikas, James M. Bennett, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 324-324
Open Access | Times Cited: 13
Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning
G.J. Correy, Moira Rachman, Takaya Togo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Chemical screening by time-resolved X-ray scattering to discover allosteric probes
Chris A. Brosey, Todd Link, Runze Shen, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1199-1209
Open Access | Times Cited: 3
β-Carboline alkaloids induce structural plasticity and inhibition of SARS-CoV-2 nsp3 macrodomain more potently than remdesivir metabolite GS-441524: computational approach
Yusuf Oloruntoyin Ayipo, Yahaya Sani Najib, Halimah Funmilayo Babamale, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 503-517
Open Access | Times Cited: 24
Intracellular mono-ADP-ribosyltransferases at the host–virus interphase
Bernhard Lüscher, Maud Verheirstraeten, Sarah Krieg, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 16
Devil's tools: SARS-CoV-2 antagonists against innate immunity
Duo Xu, Mahamaya Biswal, Arrmund Neal, et al.
Current Research in Virological Science (2021) Vol. 2, pp. 100013-100013
Open Access | Times Cited: 21
pyKVFinder: an efficient and integrable Python package for biomolecular cavity detection and characterization in data science
João Victor da Silva Guerra, Helder Veras Ribeiro Filho, Gabriel Ernesto Jara, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 20
The Third CACHE Challenge – Finding Ligands Targeting the Macrodomain of SARS-CoV-2 NSP3 Using AI-inspired and Knowledge-Based Approaches.
Suneel Kumar B.V.S, Ophélie Rostaing, Mihai Burai Patrascu, et al.
(2024)
Open Access | Times Cited: 2
ASCC1 structures and bioinformatics reveal a novel Helix-Clasp-Helix RNA-binding motif linked to a two-histidine phosphodiesterase
Naga Babu Chinnam, Roopa Thapar, Andy Arvai, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107368-107368
Open Access | Times Cited: 2
X‐ray scattering reveals disordered linkers and dynamic interfaces in complexes and mechanisms for DNA double‐strand break repair impacting cell and cancer biology
Michal Hammel, John A. Tainer
Protein Science (2021) Vol. 30, Iss. 9, pp. 1735-1756
Open Access | Times Cited: 19
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformation
My T. Nguyen, Davide Moiani, Zamal Ahmed, et al.
Progress in Biophysics and Molecular Biology (2021) Vol. 163, pp. 143-159
Open Access | Times Cited: 18
Host ADP-ribosylation and the SARS-CoV-2 macrodomain
Nícolas C. Hoch
Biochemical Society Transactions (2021) Vol. 49, Iss. 4, pp. 1711-1721
Open Access | Times Cited: 18
PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages
Diego Vinicius Santinelli Pestana, Elena Aïkawa, Sasha A. Singh, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 964-964
Open Access | Times Cited: 7
An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors
Joseph J. O’Connor, Dana Ferraris, Anthony R. Fehr
Pathogens (2023) Vol. 12, Iss. 10, pp. 1221-1221
Open Access | Times Cited: 7
SAR based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against COVID-19: A Medicinal Chemist Perspective
Anish Madan, Mansi Garg, Garvit Satija, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 14, pp. 1319-1339
Closed Access | Times Cited: 6
A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain
Ananya Anmangandla, Sadhan Jana, Kewen Peng, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 5, pp. 1200-1207
Open Access | Times Cited: 6
Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors
Behnaz Yazdani, Hajar Sirous, Simone Brogi, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2291-2291
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top